Identifying profiles of patients with bipolar i disorder who would benefit from maintenance therapy with a long-acting injectable antipsychotic / Mauricio Tohen en The Journal of Clinical Psychiatry, Año 2020 - Vol. 81 - No. 4 (Julio - Agosto)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2020 - Vol. 81 - No. 4 (Julio - Agosto) . - pp. 63-72 Título : Identifying profiles of patients with bipolar i disorder who would benefit from maintenance therapy with a long-acting injectable antipsychotic Tipo de documento: texto impreso Autores: Mauricio Tohen, Autor ; Joseph F. Goldberg, Autor ; Youssef Hassoun, Autor Fecha de publicación: 2020 Artículo en la página: pp. 63-72 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agentes antipsicóticos, Aripiprazol, Trastorno bipolar, Adherencia a la medicación, Risperidona. Resumen: People with bipolar I disorder experience an illness course marked by potentially disastrous manic episodes, disabling depressive episodes, and functional impairment. A frequent obstacle to wellness in these individuals is nonadherence to treatment. Long-acting injectable (LAI) antipsychotics have the potential to address nonadherence and thereby increase patients' chances at sustained recovery and normal psychosocial functioning. Link: ./index.php?lvl=notice_display&id=24770 [artículo] Identifying profiles of patients with bipolar i disorder who would benefit from maintenance therapy with a long-acting injectable antipsychotic [texto impreso] / Mauricio Tohen, Autor ; Joseph F. Goldberg, Autor ; Youssef Hassoun, Autor . - 2020 . - pp. 63-72. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2020 - Vol. 81 - No. 4 (Julio - Agosto) . - pp. 63-72 Palabras clave: Agentes antipsicóticos, Aripiprazol, Trastorno bipolar, Adherencia a la medicación, Risperidona. Resumen: People with bipolar I disorder experience an illness course marked by potentially disastrous manic episodes, disabling depressive episodes, and functional impairment. A frequent obstacle to wellness in these individuals is nonadherence to treatment. Long-acting injectable (LAI) antipsychotics have the potential to address nonadherence and thereby increase patients' chances at sustained recovery and normal psychosocial functioning. Link: ./index.php?lvl=notice_display&id=24770

---

1 (1 - 1 / 1)